COVAXIN
Latest news and video coverage curated from trusted media outlets
| 0 shares | ShareTweetSavePostSend |
You Might Like
Bharat Biotech founder Dr Krishna Ella awarded INSA fellowship for 2025Dr Krishna Ella, co-founder of Bharat Biotech, has been awarded the prestigious INSA India fellowship for 2025 for his significant contributions to vaccine technology and biotechnology. His work led to..IndiaTimes - Published | |
Bharat Biotech sues BHU researchers over Covaxin studyBharat Biotech has taken legal action against 11 BHU researchers and the journal Drug Safety over a study on Covaxin's side effects. Alleging defamation, Bharat Biotech seeks a permanent injunction and..IndiaTimes - Published | |
ICMR slams BHU's Covaxin study, says it wasn't part of itIndian Council of Medical Research criticizes a recently-published study on Covaxin's safety analysis for poor methodology. The study wrongly acknowledges ICMR. Director Rajiv Bahl clarifies the lack..IndiaTimes - Published | |
1 in 3 Covaxin recipients hit by adverse events: StudyNearly one-third of Covaxin recipients experienced adverse events of special interest within a year, including respiratory, skin, and musculoskeletal issues. The study also highlighted menstrual..IndiaTimes - Published | |
Covaxin had much lower adverse effects and overall favourable short-term safety profile in adolescents: StudyBharat Biotech’s indigenously developed Covid-19 vaccine Covaxin was overall found to have “much lower” AEFI (adverse effects following immunisation) rates in adolescents with a favourable..IndiaTimes - Published | |
Over 30% Covaxin takers suffered from health issues after 1 year: ReportA study from BHU analyzing the lasting impacts of Bharat Biotech's Covaxin found nearly a third of recipients reported adverse events of special interest (AESI). Among 926 participants, viral upper..IndiaTimes - Published | |
Bharat Biotech stresses on Covaxin’s safety record after AstraZeneca admits to Covishield causing rare clotting side effectsFollowing AstraZeneca's acknowledgment in a UK court that its Covid-19 vaccine triggered a rare side effect—Thrombosis with Thrombocytopenia Syndrome (TTS), Hyderabad-based vaccine manufacturer..IndiaTimes - Published | |
What to watch on OTT this weekExplore a diverse range of content on OTT this week, from the hilarious banter of Koffee with Karan featuring Varun Dhawan and Sidharth Malhotra to the emotional rollercoaster of 'Aam Aadmi Family'..IndiaTimes - Published | |
The Vaccine War script to be a featured in Oscar libraryVivek Agnihotri helmed 'The Vaccine War' has been invited by the Academy for their library. The Academy of Motion Picture Arts and Sciences reached out to the filmmaker, expressing interest in..IndiaTimes - Published | |
Vivek announces BOGO for The Vaccine WarVivek Agnihotri, director of 'The Vaccine War,' has announced a 'buy 1 get 1' ticket offer for the movie. The film has been doing well at the box office and Agnihotri wants to show appreciation to the..IndiaTimes - Published | |
The Vaccine War struggles at the BODirected by Vivek Agnihotri, The Vaccine War is based on the book ‘Going Viral’ by Prof Balram Bhargava, Director General – Indian Council of Medical Research (ICMR). It talks about the..IndiaTimes - Published | |
The Vaccine War BO day 1: the movie starts slow'The Vaccine War' is touted to be India’s first ‘bio-science’ film as it tries to present the story of the scientists who developed India’s Covid-19 vaccine, Covaxin, during the pandemic.IndiaTimes - Published | |
Covovax for adults to reach metros in a week: SIISerum Institute of India’s CEO Adar Poonawalla told TOI on Friday that doses of Covovax — Covid booster shot for adults — would reach major cities in four to five days, while a Bharat Biotech..IndiaTimes - Published | Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseCovovax can be administered to those who have already vaccinated with Covishield or Covaxin. The Drugs Controller General of India (DCGI) on January 16 had approved the market authorisation for Covovax..IndiaTimes - Published |
Amid rising viral cases, Bharat Biotech working on H3N2 vaccineAmid rising cases of H3N2 influenza virus in the country and reports of some deaths too, Hyderabad-based vaccine maker Bharat Biotech, which developed the indigenous Covaxin and intranasal vaccine..IndiaTimes - Published | Serum Institute seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adultsCovid-19 vaccine India: The Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adults who have been administered two..Zee News - Published |
Drug panel favours nod for Covovax as Covid boosterAn expert panel of the central drug regulatory authority has recommended market authorisation for Serum Institute of India’s Covid vaccine, Covovax, as a heterologous booster dose for adults who have..IndiaTimes - Published | Covovax may get approval as heterologous boosterThe government may decide on allowing Serum Institute of India’s (SII) Covovax as a heterologous booster dose, meaning it can be used for people who have taken either Covishield or Covaxin for..IndiaTimes - Published |
Ocugen announces positive top-line data for Covaxin in US trialsnewKerala.com - Published | Delhi HC makes Bharat Biotech, Centre parties in pleas seeking details on CovaxinnewKerala.com - Published |
Ocugen-Bharat Biotech Covid vaccine Covaxin meets main goals in US trialOcugen Inc said on Monday the Covid-19 vaccine developed by its Indian partner Bharat Biotech International Ltd met the main goals of a trial in the United States. The vaccine, sold under brand name..IndiaTimes - Published | |
